We are live on ! Find out more
GCP

GSA Capital Partners Portfolio holdings

AUM $1.59B
1-Year Est. Return 39.81%
This Fund
S&P 500
This Quarter Est. Return
-5.09%
1 Year Est. Return
+39.81%
3 Year Est. Return
+94.75%
5 Year Est. Return
+73.44%
10 Year Est. Return
+404.29%
AUM
$745M
AUM Growth
-$51.2M
Cap. Flow
-$4.97M
Cap. Flow %
-0.67%
Top 10 Hldgs %
3.53%
Holding
1,995
New
631
Increased
376
Reduced
341
Closed
636

Top Buys

Rank Stock Value
1
KOD icon
Kodiak Sciences
KOD
+$3.17M
2
CSTM icon
Constellium
CSTM
+$2.67M
3
KTB icon
Kontoor Brands
KTB
+$2.5M
4
SMTC icon
Semtech
SMTC
+$2.34M
5
CXT icon
Crane NXT
CXT
+$2.34M

Sector Composition

Rank Sector Weight
1 Healthcare 16.38%
2 Industrials 16.37%
3 Technology 14.13%
4 Consumer Discretionary 10.96%
5 Financials 10.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FREE
851
DELISTED
Whole Earth Brands, Inc. Class A Common Stock
FREE
$320K 0.04%
44,681
-44,959
-50% -$402K
MGRC icon
852
McGrath RentCorp
MGRC
$2.93B
$319K 0.04%
+3,759
New +$299K
INFI
853
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$319K 0.04%
+279,605
New +$334K
ACM icon
854
Aecom
ACM
$9.5B
$318K 0.04%
4,142
-1,151
-22% -$84.5K
MAS icon
855
Masco
MAS
$14.8B
$318K 0.04%
+6,239
New +$371K
FND icon
856
Floor & Decor
FND
$6.3B
$317K 0.04%
+3,911
New +$396K
TRNO icon
857
Terreno Realty
TRNO
$7.45B
$317K 0.04%
4,280
+1,821
+74% +$132K
UNH icon
858
UnitedHealth
UNH
$371B
$316K 0.04%
620
-659
-52% -$318K
KRON
859
DELISTED
Kronos Bio
KRON
$315K 0.04%
+43,562
New +$371K
MRSN
860
DELISTED
Mersana Therapeutics
MRSN
$314K 0.04%
3,148
-335
-10% -$39.1K
RAMP icon
861
LiveRamp
RAMP
$2.3B
$314K 0.04%
8,405
+2,660
+46% +$111K
KMB icon
862
Kimberly-Clark
KMB
$36B
$313K 0.04%
+2,543
New +$336K
ON icon
863
ON Semiconductor
ON
$31.6B
$312K 0.04%
4,984
-20,643
-81% -$1.26M
FOCS
864
DELISTED
Focus Financial Partners Inc. Class A
FOCS
$312K 0.04%
6,821
-15,722
-70% -$789K
INSE icon
865
Inspired Entertainment
INSE
$166M
$311K 0.04%
+25,251
New +$338K
WRB icon
866
W.R. Berkley
WRB
$26.2B
$311K 0.04%
+7,001
New +$279K
ZWS icon
867
Zurn Elkay Water Solutions
ZWS
$8.49B
$310K 0.04%
8,769
-7,408
-46% -$246K
BKR icon
868
Baker Hughes
BKR
$63.7B
$309K 0.04%
+8,500
New +$258K
CLH icon
869
Clean Harbors
CLH
$16.4B
$309K 0.04%
+2,765
New +$273K
MTLS
870
Materialise
MTLS
$395M
$309K 0.04%
+15,955
New +$321K
ZYNE
871
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
$309K 0.04%
150,914
-119,858
-44% -$285K
FOXF icon
872
Fox Factory Holding Corp
FOXF
$881M
$308K 0.04%
3,147
-3,434
-52% -$424K
GPN icon
873
Global Payments
GPN
$22.8B
$308K 0.04%
+2,248
New +$314K
OLMA icon
874
Olema Pharmaceuticals
OLMA
$1.05B
$308K 0.04%
72,287
+32,060
+80% +$177K
ELYS
875
DELISTED
Elys Game Technology, Corp. Common Stock
ELYS
$308K 0.04%
131,124
+118,311
+923% +$318K

Similar funds

GSA Capital Partners's Q1 2022 Portfolio in Review

As of Q1 2022, GSA Capital Partners held 1,995 positions worth $745M, down 6.4% from $796M the previous quarter. Its ten largest holdings account for 3.5% of the portfolio.

GSA Capital Partners's Q1 2022 filing shows 631 new, 376 increased, 341 reduced and 636 closed positions. Its largest new stake was Kodiak Sciences: 81,285 shares worth $628K. The largest sale was State Street Consumer Staples Select Sector SPDR ETF, an estimated $2.96M.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, down from 16% a quarter earlier, followed by Industrials and Technology.

  • GSA Capital Partners's largest Q1 2022 buy was Kodiak Sciences: 81,285 shares worth $628K.
  • GSA Capital Partners added most to UMB Financial in Q1 2022, an estimated $1.88M increase.
  • GSA Capital Partners's biggest Q1 2022 reduction was Cleveland-Cliffs, cutting an estimated $2.09M.
  • GSA Capital Partners fully exited State Street Consumer Staples Select Sector SPDR ETF in Q1 2022, selling an estimated $2.96M.
  • GSA Capital Partners's ten largest holdings make up 3.5% of its $745M portfolio in Q1 2022.
  • GSA Capital Partners opened 631 new positions and closed 636 in Q1 2022.
  • GSA Capital Partners's portfolio value fell 6.4% quarter-over-quarter to $745M.

Based on GSA Capital Partners's 13F filing for Q1 2022, filed 11 May 2022.